Cardium soars on wound-healing product approval

Shares of Cardium Therapeutics tripled recently after the Carmel Valley,Calif.-based company said it has received marketing approval from the U.S. Food and Drug Administration to sell Excellagen, its flagship product for diabetic foot ulcers and other skin wounds.

Shares of Cardium Therapeutics tripled recently after the Carmel Valley,Calif.-based company said it has received marketing approval from the U.S. Food and Drug Administration to sell Excellagen, its flagship product for diabetic foot ulcers and other skin wounds.

View the original here:
Cardium soars on wound-healing product approval

Related posts:

  1. Could A New Acellular Matrix Lead To Better Outcomes In Wound Healing And Tendon Coverage?
  2. NPWT/SALSA Comparative Effectiveness Study Awarded Top Honors at International Wound Healing Symposium
  3. At the Asia Pacific Burn Congress and Congress of the Asia Wound Healing Association
  4. Application of Telemedicine System With 4G and High-Resolution Video in Diagnosis and Treatment of Wounds Between Wound Healing Department and…
  5. Polymem Wound Dressing
  6. Differential Keratin Expression During Epiboly in a Wound Model of Bioengineered Skin and in Human Chronic Wounds
  7. ARANZ Medical Wound Assessment
  8. Can The Medial Plantar Artery Flap Be Beneficial For Diabetic Heel Ulcers?
  9. Wound Complications With Posterior Midline and Posterior Medial Leg Incisions: A Systematic Review
  10. Wound Gene Signatures? Ask our friends in Cardiff